狂犬病的预防注射,由于疫苗副作用和潜伏期长,除极少的一部分研究人员外,一般在咬伤后进行“暴露后的疫苗疗法”,给予连续10针以上的免疫注射。狂犬疫苗或使用方法新进展有如下三个方面:第一,是狂犬病抗血清的合并使用,抗血清于1954年在伊朗经大规模人群观察证实与疫苗合并使用有效。此后,世界卫生组织将其推荐为治疗狂犬病的原则;第二,继1963年Kissling制造地鼠肾组织疫苗后,Wiktor等用人二倍体细胞,近藤用鸡胚细胞等进行组织疫苗的研制,新近已开始实际应用。组织培养疫苗,国际校准规定免疫全 Rabies vaccination, due to the vaccine’s side effects and long latency period, is generally followed by “post-exposure vaccine therapy” after bite, giving consecutive 10 or more immunizations. Rabies vaccine or the use of new advances in the following three aspects: First, the combined use of rabies antisera, the antisera in Iran in 1954 by large-scale population confirmed the effective use of the vaccine combined. Since then, the World Health Organization recommended it as the principle of treatment of rabies. Second, following the 1963 Kissling manufacture of hamster kidney vaccine, Wiktor and other diploid cells with human, Kondo embryonic cells with tissue vaccine development, recently Has begun practical application. Tissue culture vaccines, international calibration of immunization